Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system

Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system

Abstract Background This study aimed to evaluate the reactogenicity effects of COVID-19 vaccines, used in Iran. Methods At least 1000 people were followed up with phone calls or self-report in a mobile application within 7 days after vaccination. Local and systemic reactogenicities were reported ove...

Full description

Bibliographic Details
Main Authors: Mostafa Enayatrad, Sepideh Mahdavi, Roqayeh Aliyari, Sajad Sahab-Negah, Sairan Nili, Mohammad Fereidouni, Parvin Mangolian Shahrbabaki, Alireza Ansari-Moghaddam, Abtin Heidarzadeh, Fariba Shahraki-Sanavi, Mansooreh Fateh, Hamidreza Khajeha, Zahra Emamian, Elahe Behmanesh, Hossein Sheibani, Maryam Abbaszadeh, Reza Jafari, Maryam Valikhani, Ehsan Binesh, Hamid Vahedi, Reza Chaman, Hamid Sharifi, Mohammad Hassan Emamian
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Infectious Diseases
Subjects:
Vaccine reactogenicity
Sinopharm
Sputnik V
AZD1222
COVIran Barekat
Online Access:https://doi.org/10.1186/s12879-023-08103-4

Internet

https://doi.org/10.1186/s12879-023-08103-4

Similar Items